BR9610858A - Sal de pirrolidinil metil indol - Google Patents

Sal de pirrolidinil metil indol

Info

Publication number
BR9610858A
BR9610858A BR9610858A BR9610858A BR9610858A BR 9610858 A BR9610858 A BR 9610858A BR 9610858 A BR9610858 A BR 9610858A BR 9610858 A BR9610858 A BR 9610858A BR 9610858 A BR9610858 A BR 9610858A
Authority
BR
Brazil
Prior art keywords
methyl indole
pyrrolidinyl methyl
indole salt
salt
pyrrolidinyl
Prior art date
Application number
BR9610858A
Other languages
English (en)
Inventor
Martins James Wythes
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of BR9610858A publication Critical patent/BR9610858A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR9610858A 1995-05-20 1996-04-10 Sal de pirrolidinil metil indol BR9610858A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9510223.2A GB9510223D0 (en) 1995-05-20 1995-05-20 Therapeutic agent
PCT/EP1996/001560 WO1996036632A1 (en) 1995-05-20 1996-04-10 Pyrrolidinyl methyl indole salt

Publications (1)

Publication Number Publication Date
BR9610858A true BR9610858A (pt) 1999-07-13

Family

ID=10774766

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9610858A BR9610858A (pt) 1995-05-20 1996-04-10 Sal de pirrolidinil metil indol

Country Status (42)

Country Link
US (1) US5994387A (pt)
EP (1) EP0827503B1 (pt)
JP (1) JP3233940B2 (pt)
KR (1) KR100295255B1 (pt)
CN (1) CN1063175C (pt)
AP (1) AP738A (pt)
AR (1) AR003949A1 (pt)
AT (1) ATE194986T1 (pt)
AU (1) AU701154B2 (pt)
BG (1) BG63046B1 (pt)
BR (1) BR9610858A (pt)
CA (1) CA2219631C (pt)
CO (1) CO5040221A1 (pt)
CZ (1) CZ287939B6 (pt)
DE (1) DE69609504T2 (pt)
DK (1) DK0827503T3 (pt)
DZ (1) DZ2034A1 (pt)
ES (1) ES2148753T3 (pt)
GB (1) GB9510223D0 (pt)
GR (1) GR3034290T3 (pt)
HK (1) HK1017884A1 (pt)
HR (1) HRP960223B1 (pt)
HU (1) HU217657B (pt)
IL (1) IL118239A (pt)
IS (1) IS1908B (pt)
LV (1) LV11992B (pt)
MA (1) MA23876A1 (pt)
MX (1) MX9708966A (pt)
MY (1) MY132066A (pt)
NO (1) NO312068B1 (pt)
NZ (1) NZ306448A (pt)
OA (1) OA10747A (pt)
PL (1) PL183142B1 (pt)
PT (1) PT827503E (pt)
RU (1) RU2161618C2 (pt)
SK (1) SK281782B6 (pt)
TN (1) TNSN96074A1 (pt)
TR (1) TR199701397T1 (pt)
UA (1) UA44320C2 (pt)
WO (1) WO1996036632A1 (pt)
YU (1) YU29496A (pt)
ZA (1) ZA963938B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
US20100266638A1 (en) * 2004-02-26 2010-10-21 Allergan, Inc. Headache treatment method
WO2014012859A1 (en) * 2012-07-19 2014-01-23 Boehringer Ingelheim International Gmbh Fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy- chinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one, its use as medicament and the preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3906406C1 (pt) * 1989-03-01 1990-10-25 Goedecke Ag, 1000 Berlin, De
RO111767B1 (ro) * 1990-10-15 1997-01-30 Pfizer Derivati de indol, procedee si intermediari pentru prepararea acestora, compozitii farmaceutice si metoda pentru tratarea unor afectiuni
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
AP486A (en) * 1993-04-27 1996-04-16 Pfizer Indole derivatives.

Also Published As

Publication number Publication date
IL118239A (en) 2000-10-31
CO5040221A1 (es) 2001-05-29
CZ364897A3 (cs) 1998-11-11
ATE194986T1 (de) 2000-08-15
IS4605A (is) 1997-10-30
CA2219631C (en) 2001-01-23
IS1908B (is) 2003-12-31
CN1063175C (zh) 2001-03-14
ES2148753T3 (es) 2000-10-16
DK0827503T3 (da) 2000-11-20
HRP960223A2 (en) 1997-10-31
LV11992A (lv) 1998-03-20
BG63046B1 (bg) 2001-02-28
NO312068B1 (no) 2002-03-11
HUP9801761A3 (en) 1999-06-28
PT827503E (pt) 2000-11-30
DE69609504D1 (de) 2000-08-31
RU2161618C2 (ru) 2001-01-10
KR19990014934A (ko) 1999-02-25
MA23876A1 (fr) 1996-12-31
WO1996036632A1 (en) 1996-11-21
DE69609504T2 (de) 2000-12-14
NO975210D0 (no) 1997-11-13
CN1185152A (zh) 1998-06-17
DZ2034A1 (fr) 2002-07-21
PL183142B1 (pl) 2002-05-31
CZ287939B6 (cs) 2001-03-14
BG102053A (en) 1998-06-30
HUP9801761A2 (hu) 1999-05-28
YU29496A (sh) 1998-12-23
JP3233940B2 (ja) 2001-12-04
HRP960223B1 (en) 2000-12-31
SK154197A3 (en) 1999-01-11
MX9708966A (es) 1998-03-31
PL323143A1 (en) 1998-03-16
SK281782B6 (sk) 2001-07-10
OA10747A (en) 2002-12-11
AU5500596A (en) 1996-11-29
TNSN96074A1 (fr) 2005-03-15
IL118239A0 (en) 1996-09-12
MY132066A (en) 2007-09-28
GB9510223D0 (en) 1995-07-19
UA44320C2 (uk) 2002-02-15
AU701154B2 (en) 1999-01-21
EP0827503B1 (en) 2000-07-26
HK1017884A1 (en) 1999-12-03
HU217657B (hu) 2000-03-28
AP738A (en) 1999-03-23
NO975210L (no) 1997-11-13
JPH10506639A (ja) 1998-06-30
GR3034290T3 (en) 2000-12-29
TR199701397T1 (xx) 1998-03-21
NZ306448A (en) 1998-10-28
ZA963938B (en) 1997-11-17
US5994387A (en) 1999-11-30
AP9600801A0 (en) 1996-04-30
CA2219631A1 (en) 1996-11-21
EP0827503A1 (en) 1998-03-11
LV11992B (en) 1998-06-20
KR100295255B1 (ko) 2001-08-07
AR003949A1 (es) 1998-09-30

Similar Documents

Publication Publication Date Title
DE69609772D1 (de) 3-Substituierte Oxindolderivate als Kaliumkanalmodulatoren
FI970800A (fi) Migreeninvastaisia indolijohdossuoloja
BR9606743A (pt) Derivados indol úteis no tratamento de osteoporose
NO972634L (no) Konfigurasjon for streamere
DE69626585D1 (de) Ausbalancierter Zeilendrucker
BR9610858A (pt) Sal de pirrolidinil metil indol
ATE193701T1 (de) Substituierte indol-derivate
ATE241615T1 (de) 5-heteroaryl-substituierte indole
NO975811D0 (no) Ny anvendelse for pyrrolderivater
IS1809B (is) Kasttrekt fyrir fiskilínu
ATE210117T1 (de) Indolderivate als melatoninanaloge
SI0827503T1 (en) Pyrrolidinyl methyl indole salt
DE59605373D1 (de) Substituierte Indol-Derivate
KR970048346U (ko) 통신기기 유니트용 장탈착장치
BR9509331A (pt) Diluente de esperma compreendendo um derivado de indol
ITMI951687A0 (it) Composti indolici
ITMI950030A0 (it) Composti indolici
KR970012927U (ko) 리어콤비네이션램프의 방수용 글로메트
KR970023909U (ko) 로드홀더
KR960028958U (ko) 샷틀용 홀더
GB9523097D0 (en) Indole derivatives
KR970003793U (ko) 경운기용 로타리 지지장치
KR960034531U (ko) 재제염의 채염배분장치
KR970046855U (ko) 라인홀더
KR970000690U (ko) 경운기용 톱밥제조기

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM O ARTIGO 8O DA LPI.